Product Name	Recombinant Rabbit Anti-Influenza A H1N1 Monoclonal Antibody
Cat No.	SLA0625M
Chinese Name	流感病毒A核蛋白单克隆抗体
Alias	FLUAVs7gp2;
Host Species	Mouse
Isotype	IgG
Clonality	Monoclonal
Clone No.	3G2
React Species	Influenza A Nucleoprotein [A/Victoria/4897/2022 (H1N1)]
Applications	WB (1:500-2000) Not yet tested in other applications. Optimal working dilutions must be determined by the end user.
Immunogen	Recombinant Influenza A virus H1N1(A/Victoria/4897/2022)Nucleoprotein
Purification	affinity purified by Protein A
Concentration	1mg/ml
Predicted MW.	57 kDa
Observed MW.	57 kDa
Storage	0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Background	The nucleoprotein (NP) of Influenza virus encapsulates the negative strand of the viral RNA and is essential for replicative transcription. It may also be involved in other essential functions throughout the virus life cycle. As well as binding ssRNA, NP is able to self associate to form large oligomeric complexes. NP is able to interact with a variety of other macromolecules of both viral and cellular origins. It binds the PB1 and PB2 subunits of the polymerase and the matrix protein M1. "NP has also been shown to interact with at least four cellular polypeptide families: nuclear import receptors of the importin class, filamentous (F) actin, the nuclear export receptor CRM1 and a DEAD box helicase BAT1/UAP56" (Portela et al 2002).
Attention	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

 

Validation Images

Figure 1. 20 ng rInfluenza A virus H1N1(A/Victoria/4897/2022)Nucleoprotein-His protein (SL44023P) per lane probed with Influenza A virus Nucleoprotein H1N1 monoclonal antibody respectively, unconjugated (SLA0625M) at 1:1000 dilution and 4°C overnight incubation. Followed by corresponding conjugated secondary antibody incubation at r.t. for 60 min.

 

FOR RESEARCH USE ONLY. Not for use in diagnostic or therapeutic procedures.